// App-Quantinova.ai

e12111 : Pathologic complete response and serial circulating tumor cell monitoring during neoadjuvant therapy in nonmetastatic triple-negative breast cancer patients.

Researchers

Presenter

  • Carolyn S. Hall

Principal Investigators

  • Kenneth R. Hess

  • Elizabeth Ravenberg

  • Alyson Clayborn

  • Salyna Meas

  • Stacy L. Moulder

  • Alastair Mark Thompson

  • Anthony Lucci

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Baylor College of Medicine, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved